收藏切换
Thoughts and recommendations arising from a review of “subcenter contracts” for clinical research initiated by investigators
收藏切换
Ye CAO1, Li-ying QIN2, Hui JIANG3, Shuang-zhen CHEN4, Can LI5, Ting LIN6, Jing-min ZHANG4, Pan WANG7
Chinese Journal of New Drugs | 2021, 30(24) : 2288 - 2294
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(24): 2288-2294
Thoughts and recommendations arising from a review of “subcenter contracts” for clinical research initiated by investigators
Full
Ye CAO1, Li-ying QIN2, Hui JIANG3, Shuang-zhen CHEN4, Can LI5, Ting LIN6, Jing-min ZHANG4, Pan WANG7
Affiliations
  • 1Department of Clinical Research, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
  • 2Institute of Clinical Study, The First Hospital of Nanchang, Nanchang 330008, China
  • 3Department of Science and Education, Zhangzhou Affiliated Hospital of Fujiang Medical University, Zhangzhou 363000, China
  • 4Department of Medical Oncology, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
  • 5Department of Colorectal Surgery, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
  • 6Department of Thoracic Surgery, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
  • 7Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
Published: 2021-12-30
Outline
收藏切换

The “subcenter contract” is the basis of multi-center research initiated by investigators. It is a crucial contract document for agreeing on the mutual power and responsibilities of the various institutions participating in the study. This paper analyzed the general characteristics of 158 subcenter contracts for investigator initiated trials (IIT) and assessed the common problems. All the 158 IIT subcenter contracts were in Chinese text, most contracts were signed with university affiliated hospitals and prefecture-level hospitals, most contracts were signed with oncology hospitals and general hospitals, and most of the contracts adopted unified templates of the leading units. Among the 40 template contracts, the common problems were as follows: 45.9% of the contracts did not mention the way of providing research drugs, 51.3% did not specify the adverse drug reaction monitoring and reporting responsibilities during the study, 60% did not mention the subject damage liability, 50% did not state who were responsible for data preservation after the end of the study, misplacement of the regulations that IIT should follow or refer to, missing or unclear key elements of the contract, unclear responsibility for clinical research and supervision, etc. According to the above analysis results, this paper respectively put forward thoughts and suggestions on the legal and regulatory basis to be followed by IIT, the provision of research drugs, adverse reaction monitoring report, the confidentiality and preservation of research data, intellectual property sharing, subject damages, and the key elements of research contract.

investigator initiated trials  /  subcenter contract  /  intellectual property rights  /  subject damages compensation
曹烨, 秦丽英, 蒋辉, 陈双珍, 李粲, 林婷, 张靖敏, 王盼. 从研究者发起的临床研究“分中心合同”审查引发的思考和建议. 中国新药杂志, 2021 , 30 (24) : 2288 -2294 .
Ye CAO, Li-ying QIN, Hui JIANG, Shuang-zhen CHEN, Can LI, Ting LIN, Jing-min ZHANG, Pan WANG. Thoughts and recommendations arising from a review of “subcenter contracts” for clinical research initiated by investigators[J]. Chinese Journal of New Drugs, 2021 , 30 (24) : 2288 -2294 .
Year 2021 volume 30 Issue 24
45
6
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-28
  • Published:2021-12-30
Article Data
Affiliations
History
  • Accepted:2021-10-08
Affiliations
    1Department of Clinical Research, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
    2Institute of Clinical Study, The First Hospital of Nanchang, Nanchang 330008, China
    3Department of Science and Education, Zhangzhou Affiliated Hospital of Fujiang Medical University, Zhangzhou 363000, China
    4Department of Medical Oncology, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
    5Department of Colorectal Surgery, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
    6Department of Thoracic Surgery, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
    7Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Hospital, Guangzhou 510060, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT